Vasculitis & polymyalgia rheumatica

Epidemiology of eosinophilic granulomatosis with polyangiitis in Northern Italy: a population-based capture-recapture study

Semin Arthritis RheumPublished Population-based capture-recapture study

Authors' conclusion

EGPA prevalence in Northern Italy is among the highest reported in Europe, likely reflecting near-complete case ascertainment through integrated health data sources rather than true geographic variation.

Study context

Population
Patients with eosinophilic granulomatosis with polyangiitis (EGPA) in the Reggio Emilia area, Northern Italy, 1991–2022 (mean age 55 years, 75% female)36 prevalent cases
Participants
40 patients
Outcome
Prevalence and incidence of EGPA
Methodological detailsmulti-source capture-recapture, seven independent sources, 2022 ACR/EULAR classification criteria
  • Multi-source capture-recapture
  • Seven independent sources
  • 2022 ACR/EULAR classification criteria

Main finding

As reported in the abstract

Crude prevalence per million inhabitants (95% CI 68-72), January 1, 2023

68

Missed prevalent cases estimated by best-fitting capture-recapture model

0

95% CI 0 to 2

Age- and sex-standardized incidence per million inhabitants, 2001–2022

3.31

95% CI 2.24–4.37

Incident cases identified, 2001–2022

37

Observational data: associations, not effects.

Further findings

Standardized incidence by period, per million inhabitants

2001-2011
2.83 (95% CI 1.39-4.27)
2012-2022
3.59 (95% CI 2.08-5.09)
  • 0 missed cases in both periods (95% CI 0-3 and 0-2, respectively)

Source capture of prevalent cases

Hospital discharge data
25%
Exemption registry
86%

Original publication

Epidemiology of eosinophilic granulomatosis with polyangiitis in Northern Italy: a population-based capture-recapture study. Semin Arthritis Rheum. Published 29 July 2026. doi:10.1016/j.semarthrit.2026.153050

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.